|
| 三孚新科(688359)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-05-22 | 4295.20 | 46.28% | 9280.75 | 0.00 | 4985.46 | 53.72% | 首发原股东限售股份 | | 2023-06-08 | 11.25 | 0.12% | 4996.80 | 4295.20 | 4996.80 | 53.78% | 股权激励一般股份 | | 2023-05-22 | 115.23 | 1.24% | 4985.55 | 4295.20 | 4985.46 | 53.72% | 首发战略配售股份 | | 2022-12-06 | 62.75 | 0.68% | 4895.03 | 4385.72 | 4895.03 | 52.74% | 股权激励一般股份 | | 2022-05-23 | 2618.16 | 28.40% | 4832.72 | 4385.28 | 4832.72 | 52.43% | 首发原股东限售股份 | | 2021-11-22 | 99.74 | 1.08% | 2304.64 | 6913.36 | 2304.64 | 25.00% | 首发机构配售股份 |
|